BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 34115762)

  • 1. Inactivation of SARS-CoV-2 virus in saliva using a guanidium based transport medium suitable for RT-PCR diagnostic assays.
    Banik S; Saibire K; Suryavanshi S; Johns G; Chakravorty S; Kwiatkowski R; Alland D; Banada PP
    PLoS One; 2021; 16(6):e0252687. PubMed ID: 34115762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of SARS-CoV-2 virus in saliva using a guanidium based transport medium suitable for RT-PCR diagnostic assays.
    Banik S; Saibire K; Suryavanshi S; Johns G; Chakravorty S; Kwiatkowski R; Alland D; Banada P
    medRxiv; 2021 Jan; ():. PubMed ID: 33501462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sample collection and transport strategies to enhance yield, accessibility, and biosafety of COVID-19 RT-PCR testing.
    Banada P; Elson D; Daivaa N; Park C; Desind S; Montalvan I; Kwiatkowski R; Chakravorty S; Alland D; Xie YL
    J Med Microbiol; 2021 Sep; 70(9):. PubMed ID: 34486972
    [No Abstract]   [Full Text] [Related]  

  • 4. Collection and transportation of SARS-CoV-2 and influenza A virus diagnostic samples: Optimizing the usage of guanidine-based chaotropic salts for enhanced biosafety and viral genome preservation.
    Komu JG; Jamsransuren D; Matsuda S; Ogawa H; Takeda Y
    Biochem Biophys Res Commun; 2024 Jun; 715():149994. PubMed ID: 38692139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of self-collected nasal, urine, and saliva samples for molecular detection of SARS-CoV-2 using an EUA approved RT-PCR assay and a laboratory developed LAMP SARS-CoV-2 test.
    Purcell-Wiltz A; Zamuner FT; Caraballo K; De Jesus L; Miranda Y; Ortiz D; Negrón AG; Ortiz AC; Baez A; Romaguera J; Jiménez I; Ortiz A; Acevedo J; Viera L; Sidransky D; Guerrero-Preston R
    Immun Inflamm Dis; 2024 Jun; 12(6):e1285. PubMed ID: 38888444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Copan eNAT Transport System To Address Challenges in COVID-19 Diagnostics in Regions with Limited Testing Access.
    Richard-Greenblatt M; Comar CE; Flevaud L; Berti M; Harris RM; Weiss SR; Glaser L
    J Clin Microbiol; 2021 Apr; 59(5):. PubMed ID: 33579730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Saliva is Comparable to Nasopharyngeal Swabs for Molecular Detection of SARS-CoV-2.
    Callahan C; Ditelberg S; Dutta S; Littlehale N; Cheng A; Kupczewski K; McVay D; Riedel S; Kirby JE; Arnaout R
    Microbiol Spectr; 2021 Sep; 9(1):e0016221. PubMed ID: 34406838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of SARS-CoV-2 in saliva: implications for specimen transport and storage.
    Williams E; Isles N; Chong B; Bond K; Yoga Y; Druce J; Catton M; Ballard SA; Howden BP; Williamson DA
    J Med Microbiol; 2021 Feb; 70(2):. PubMed ID: 33270005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effects of viral-transport-medium heat inactivation upon downstream SARS-CoV-2 detection in patient samples.
    Thompson JL; Downie Ruiz Velasco A; Cardall A; Tarbox R; Richardson J; Clarke G; Lister M; Howson-Wells HC; Fleming VM; Khakh M; Sloan T; Duckworth N; Walsh S; Denning C; McClure CP; Benest AV; Seedhouse CH
    J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33734960
    [No Abstract]   [Full Text] [Related]  

  • 10. A Community Study of SARS-CoV-2 Detection by RT-PCR in Saliva: A Reliable and Effective Method.
    Fronza F; Groff N; Martinelli A; Passerini BZ; Rensi N; Cortelletti I; Vivori N; Adami V; Helander A; Bridi S; Pancher M; Greco V; Garritano SI; Piffer E; Stefani L; De Sanctis V; Bertorelli R; Pancheri S; Collini L; Dassi E; Quattrone A; Capobianchi MR; Icardi G; Poli G; Caciagli P; Ferro A; Pizzato M
    Viruses; 2022 Feb; 14(2):. PubMed ID: 35215902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multisite Clinical Validation of Isothermal Amplification-Based SARS-CoV-2 Detection Assays Using Different Sampling Strategies.
    Desai KT; Alfaro K; Mendoza L; Faron M; Mesich B; Maza M; Dominguez R; Valenzuela A; Acosta CD; Martínez M; Felix JC; Masch R; Smith JS; Gabrilovich S; Wu T; Plump M; Novetsky AP; Einstein MH; Douglas NC; Cremer M; Wentzensen N
    Microbiol Spectr; 2021 Oct; 9(2):e0084621. PubMed ID: 34668736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of stability and inactivation methods of SARS-CoV-2 in context of laboratory settings.
    Widera M; Westhaus S; Rabenau HF; Hoehl S; Bojkova D; Cinatl J; Ciesek S
    Med Microbiol Immunol; 2021 Aug; 210(4):235-244. PubMed ID: 34196781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of SARS-CoV-2 detection with the Cobas® 6800/8800 system on gargle samples using two sample processing methods with combined oropharyngeal/nasopharyngeal swab.
    Benoit P; Labbé AC; Lalancette L; Gagnon S; Bonneau E; Lavallée C; Roger M; Fafard J; Dumaresq J; Beauchemin S; Coutlée F;
    J Med Virol; 2021 Dec; 93(12):6837-6840. PubMed ID: 34324212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of saliva with oral and nasopharyngeal swabs for SARS-CoV-2 detection on various commercial and laboratory-developed assays.
    Labbé AC; Benoit P; Gobeille Paré S; Coutlée F; Lévesque S; Bestman-Smith J; Dumaresq J; Lavallée C; Houle C; Martin P; Mak A; Gervais P; Langevin S; Jacob-Wagner M; Gagnon S; St-Hilaire M; Lussier N; Yechouron A; Roy D; Roger M; Fafard J
    J Med Virol; 2021 Sep; 93(9):5333-5338. PubMed ID: 33851739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RT-PCR/MALDI-TOF mass spectrometry-based detection of SARS-CoV-2 in saliva specimens.
    Hernandez MM; Banu R; Shrestha P; Patel A; Chen F; Cao L; Fabre S; Tan J; Lopez H; Chiu N; Shifrin B; Zapolskaya I; Flores V; Lee PY; Castañeda S; Ramírez JD; Jhang J; Osorio G; Gitman MR; Nowak MD; Reich DL; Cordon-Cardo C; Sordillo EM; Paniz-Mondolfi AE
    J Med Virol; 2021 Sep; 93(9):5481-5486. PubMed ID: 33963565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNase in the saliva can affect the detection of severe acute respiratory syndrome coronavirus 2 by real-time one-step polymerase chain reaction using saliva samples.
    Nishibata Y; Koshimoto S; Ogaki K; Ishikawa E; Wada K; Yoshinari M; Tamura Y; Uozumi R; Masuda S; Tomaru U; Ishizu A
    Pathol Res Pract; 2021 Apr; 220():153381. PubMed ID: 33640711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Pool Testing in Detection of Asymptomatic Patients with COVID-19.
    Smalley DL; Cisarik PM; Grantham J; Cloud W; Neil RB; DePriest P
    Lab Med; 2021 Jan; 52(1):e15-e16. PubMed ID: 33206195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of Severe Acute Respiratory Syndrome Coronavirus 2 Real-Time RT-PCR Tests on Oral Rinses and Saliva Samples.
    Babady NE; McMillen T; Jani K; Viale A; Robilotti EV; Aslam A; Diver M; Sokoli D; Mason G; Shah MK; Korenstein D; Kamboj M
    J Mol Diagn; 2021 Jan; 23(1):3-9. PubMed ID: 33217552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid processing of SARS-CoV-2 containing specimens for direct RT-PCR.
    Chomczynski P; Chomczynski PW; Kennedy A; Rymaszewski M; Wilfinger WW; Heiny JA; Mackey K
    PLoS One; 2021; 16(2):e0246867. PubMed ID: 33566873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential False-Negative Nucleic Acid Testing Results for Severe Acute Respiratory Syndrome Coronavirus 2 from Thermal Inactivation of Samples with Low Viral Loads.
    Pan Y; Long L; Zhang D; Yuan T; Cui S; Yang P; Wang Q; Ren S
    Clin Chem; 2020 Jun; 66(6):794-801. PubMed ID: 32246822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.